Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. LLY.US
LLY.US logo

LLY.US News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LLY.US News

PHARMARON Jumps Over 12% Following Production Partnership with Eli Lilly for Orforglipron

Mar 12 2026aastocks

Novo Nordisk Stock Plummets Nearly 11% as CagriSema Underperforms Compared to Eli Lilly's Leading Weight Loss Drug

Feb 23 2026aastocks

JPM Assigns HKD111 Target Price to INNOVENT BIO; Strategic Alliance with Eli Lilly Exceeds Expectations

Feb 10 2026aastocks

UBS Anticipates Benefits from INNOVENT BIO's Collaboration with Eli Lilly for Drug Development Goals

Feb 10 2026aastocks

CLSA Increases INNOVENT BIO's Target Price to HKD130.2, Maintains Overweight Rating

Feb 10 2026aastocks

G Sachs Assigns Buy Rating to INNOVENT BIO Following Strengthened Long-term Collaboration with Eli Lilly

Feb 09 2026aastocks

INNOVENT BIO Rises Approximately 6% Following Global Partnership with Eli Lilly

Feb 09 2026aastocks

M Stanley Identifies Top Thematic Investment Opportunities in the Americas, Featuring US Stocks (Table)

Jan 20 2026aastocks

LLY.US Events

No data

No data

LLY.US Monitor News

No data

No data

LLY.US Earnings Analysis

No Data

No Data

People Also Watch